Tentler JJ, Lang J, Capasso A, Kim DJ, et al. RX-5902, a novel beta-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer. BMC Cancer 2020;20:1063.
PMID: 33148223